Balance Sheet: Assets
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Common Stock Valuation Ratios
- Price to FCFE (P/FCFE)
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Abbott Laboratories, consolidated balance sheet: assets (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Liquidity and Cash Management
-
Cash and cash equivalents show notable fluctuations, increasing from $3,377 million in early 2020 to a peak of $9,799 million by the end of 2021, followed by a general decline through 2023 before stabilizing around $6,500-$7,500 million into 2025. This indicates periods of strong liquidity build-up, possibly from operational cash flow or financing activities, countered by subsequent utilization or investment.
Short-term investments have remained relatively stable but with slight volatility, generally staying within a $200-$450 million range, without a clear trend upward or downward.
- Receivables and Inventory Trends
-
Trade receivables have shown a gradual increase over the observed period, rising from $5,292 million to about $8,138 million by late 2025. The overall trend suggests expanding sales or credit extension.
Inventories, comprising finished products, work in process, and materials, exhibit growth over time. Finished products increased from $2,873 million to a high near $4,319 million, while work in process and materials also increased moderately. Total inventories peaked around 2024, reflecting higher production or stockpiling, possibly to meet anticipated demand or supply chain considerations.
- Current Assets
-
Current assets rose steadily from $15,498 million in early 2020 to a peak near $24,839 million in late 2025. The growth is driven primarily by increases in cash and equivalents, trade receivables, and inventories, indicating an overall expansion in short-term resources.
- Long-Term Assets and Fixed Asset Management
-
Property and equipment at cost increased from $16,707 million to about $24,816 million by 2025, representing consistent capital expenditures. However, accumulated depreciation also rose markedly, reflecting asset aging and systematic use of fixed assets.
Net property and equipment values increased moderately, suggesting investments are replacing or exceeding asset depreciation.
- Intangibles and Goodwill
-
Intangible assets, net of amortization, demonstrate a steady decline from $16,265 million to approximately $5,598 million, indicating ongoing amortization or write-downs exceeding new additions. This reduction may impact future earnings due to diminishing intangible asset bases.
Goodwill figures remained relatively stable, fluctuating slightly but maintaining a level near $23 billion, implying few significant acquisitions or impairments during this period.
- Deferred Income Taxes and Other Assets
-
Deferred income taxes and other assets increased significantly from $3,390 million to $17,318 million, especially with a large jump around 2024. This may be due to changes in tax positions, asset revaluations, or other non-current recoverable items impacting long-term asset quality and tax planning.
- Total Asset Base
-
Total assets experienced overall growth from approximately $66,777 million to over $84,000 million, reflecting the company’s asset expansion across current and long-term holdings. The growth is underpinned by increasing investments in inventory, property, and deferred tax assets, despite the reduction in intangible assets.